BeStock  
Markets › Compare › SRPT vs DMRA

SRPT vs DMRA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
SRPT · Sarepta Therapeutics$13.33 ▼ 5.93%
DMRA · Damora Therapeutics$23.22 ▼ 4.44%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

62101140179218Nov 24, '25May 26, '26Nov 20, '26
  • SRPT -29.5%
  • DMRA +42.4%

Head to head

MetricSRPTDMRA
Price$13.33$23.22
Change today▼ 5.93%▼ 4.44%
Market cap$1.43B$1.44B
Return, 3 months-26.5%-23.4%
Return, year to date-38.1%+0.9%
Return, 1 year-24.6%+38.5%
P/E (TTM)–13.6
P/B0.93.9
P/E percentile vs own 5y43rd99th
Dividend yield––
Revenue growth (YoY, latest qtr)-4.5%–
Net profit growth (YoY)+43.7%-921.1%
Gross margin56.8%–
Operating margin-0.4%–
Net margin-5.9%–
Return on equity-8.0%-156.6%
Analyst target vs. price+67.5%+101.0%
Analyst buy share20%100%
RSI (14)2554
30-day volatility59.6%61.9%
Max drawdown, 1 year-44.1%-46.9%
Trend readStrong downtrendLeaning bullish
Analyst consensusHoldBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • DMRA is the largest of the group by market value.
  • DMRA has returned the most over the past year.
  • SRPT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top